Comparison of Pharmacodynamic Effects of Tirofiban vs. Cangrelor in N-STEMI Patients Undergoing Percutaneous Coronary Intervention
Phase of Trial: Phase IV
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Cangrelor (Primary) ; Tirofiban (Primary)
- Indications Myocardial infarction
- Focus Pharmacodynamics
- 09 Feb 2018 Planned End Date changed from 1 May 2018 to 29 May 2019.
- 09 Feb 2018 Planned primary completion date changed from 1 Apr 2018 to 1 Apr 2019.
- 09 Feb 2018 Status changed from not yet recruiting to recruiting.